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Background
The use of the microarray tool is an essential advantage
in the allergy diagnosis process in patients with multiple
sensitizations showing clinical patterns attributable to
the underlying cross-reaction to a single or multiple
panallergen. Among panallergens LTP is a thermostable
and resistant to pepsin digestion allergen. This features
makes it a potent food allergens and explains the fre-
quent development of systemic symptoms.
Objective
Identify the allergen source which is causing complex
clinical patterns in pediatric patients with multiple
sensitizations.
Methods
We studied 11 oupatients children (M 6 F 5, mean
age10,45 years, range 6-17 years) with multiple sensitiza-
tions and high degree of severity of systemic manifesta-
tions: 4 patients had generalized urticaria, 5 patients had
angioedema, and 2 patients had anaphylaxis. All children
filled a questionnaire related to the personal history of
allergy and underwent to the SPT with commercial
extracts and fresh food. The in vitro test were per-
formed to assess the total IgE, eosinophil count and to
search the specific IgE recombinant allergenic molecules
with microarray technique.
Results
The most significant result is the finding of sensitization
to the family of panallergens LTP in 7 of 11 patients. In
the majority of patiens (63.6%) with high severity of
clinical manifestation, e.i. anaphylaxis and generalized
urticaria the LTP sensitization was the only allergen
source confirming the role of this molecule in the cross-
reaction mechanism.
Conclusion
This study provided us a good information in the diag-
nostic evaluation process of pediatric patients with aller-
gic multiple sensitizations and serious clinical patterns
in order to plan in real life the long-term management
considering the applicability of preventive measure.
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